Article
Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
Journal of medical genetics - 1 Aug 2022
Topaloudi Apostolia, Zagoriti Zoi, Flint Alyssa Camille, Martinez Melanie Belle, Yang Zhiyu, Tsetsos Fotis, Christou Yiolanda-Panayiota, Lagoumintzis George, Yannaki Evangelia, Zamba-Papanicolaou Eleni, Tzartos John, Tsekmekidou Xanthippi, Kotsa Kalliopi, Maltezos Efstratios, Papanas Nikolaos, Papazoglou Dimitrios, Passadakis Ploumis, Roumeliotis Athanasios, Roumeliotis Stefanos, Theodoridis Marios, Thodis Elias, Panagoutsos Stylianos, Yovos John, Stamatoyannopoulos John, Poulas Konstantinos, Kleopa Kleopas, Tzartos Socrates, Georgitsi Marianthi, Paschou Peristera
Abstract excerpt
BACKGROUND: Myasthenia gravis (MG) is a rare autoimmune disorder affecting the neuromuscular junction (NMJ). Here, we investigate the genetic architecture of MG via a genome-wide association study (GWAS) of the largest MG data set analysed to date. METHODS: We performed GWAS meta-analysis integrating three different data sets (total of 1401 cases and 3508 controls). We carried out human leucocyte antigen (HLA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.